The Internet of Things Making Headlines
Last week, we announced that we provided $5 million in a Series B financing for ThingWorx, a disruptive technology that revolutionizes how people, systems and…
Posted by
Last week, we announced that we provided $5 million in a Series B financing for ThingWorx, a disruptive technology that revolutionizes how people, systems and…
Posted by
Safeguard Scientifics’ value creation strategy is to deploy capital and build value in our partner companies. One of the best ways to evaluate our progress is…
Posted by
Last year around this time, as we headed into 2010 and were making plans for the coming year, we were in the midst of the…
Posted by
Earlier this quarter, we announced that partner companies Clarient (Nasdaq: CLRT) and Avid Radiopharmaceuticals had signed definitive agreements to be acquired by GE Healthcare and…
Posted by
For the second time in as many weeks, I am pleased to announce that a major player in the pharmaceutical industry has recognized the value…
Posted by
Earlier today in our third quarter results conference call, we announced that our aggregate partner company revenue increased 73 percent in Q3, and that for…
Posted by
Safeguard Scientifics’ partner company NuPathe submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA was filed for ZelrixTM,…
Posted by
Thank you to those who were able to attend Safeguard Scientifics’ Investor Day 2010 either in person or via webcast. For those of you were…
Posted by
Just a quick reminder that Safeguard Scientifics’ Investor Day 2010 event will be held next Tuesday, October 5, from 8:00 a.m. – 11:30 a.m. at…
Posted by